Novozymes B A/S
Novozymes B A/S
-0,32 %
276,70 DKK
-0,90
Kurs
276,70
Høj
280,00
Ændring
-0,32 %
Lav
276,70
Opdateret
21-08-2019
Åben
278,40
Nyheder om Novozymes B A/S
Factsheet for Novozymes B A/S
Company Profile
Description
Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.
Key Stats
Website: http://www.novozymes.com
Headquarter country: Denmark
Employees: 6.236
Market Cap (at close 20-08-2019): DKK 79B
Fiscal Year Ends: december
Stats

Stats 2018 2017 2016 2015 2014
Price/Earnings 26,90 33,80 25,30 37,50 33,10
Forward Price/Earnings 24,00 30,70 22,40 30,90 33,20
Price/Free Cash Flow 37,80 42,10 29,70 53,50 18,40
Return on Assets 16,90 16,80 16,70 15,60 14,50
Return on Equity 28,40 27,10 26,20 24,70 22,60
Return on Invested Capital 22,90 23,20 23,30 21,90 19,80
Dividend


Dividend/Share:4,50
Ex. Dividend Date:31-12-2018
Trailing Dividend Yield:1,80
Payout Ratio:44,72
Date Currency Amount
31-03-2019 DKK 5,00
31-03-2018 DKK 4,50
31-03-2017 DKK 4,00
31-03-2016 DKK 3,50
31-03-2015 DKK 3,00
31-03-2014 DKK 2,50
Income Statement

Revenue 2018 2017 2016 2015 2014
Total Revenue 14.390,00 14.531,00 14.142,00 14.002,00 12.459,00
Gross Profit 8,26 8,41 8,13 8,13 7,15
Gross Margin % 57,37% 57,90% 57,46% 58,06% 57,38%
Operating Expenses 2018 2017 2016 2015 2014
EBITDA 4.960,00 4.943,00 4.886,00 4.605,00 4.203,00
Net income 3.226,00 3.119,00 3.050,00 2.823,00 2.526,00
Basic Earnings Per Share 11,11 10,56 10,15 9,23 8,10
Operating Income 4,07 4,11 3,95 3,88 3,15
Operating Margin % 28,28% 28,31% 27,90% 27,74% 25,26%
Cash Flow

Cash Flow 2018 2017 2016 2015 2014
Operating Cash Flow 3.679,00 4.063,00 3.840,00 3.339,00 4.525,00
Capital Expenditures -1.392,00 -1.692,00 -1.216,00 -1.031,00 -723,00
Free Cash Flow 2.287,00 2.371,00 2.624,00 2.308,00 3.802,00
Balance Sheet

Assets 31-12-2018 31-12-2017 31-12-2016 31-12-2015 31-12-2014
Current Assets 6.835,00 6.137,00 6.393,00 6.148,00 7.311,00 5.830,00
Long Term Assets 12.862,00 12.236,00 12.266,00 11.643,00 11.115,00 10.676,00
Total Assets 19.697,00 18.373,00 18.659,00 17.791,00 18.426,00 16.506,00
Liabilities 31-12-2018 31-12-2017 31-12-2016 31-12-2015 31-12-2014
Total Current Liabilities 5.525,00 4.577,00 3.562,00 3.300,00 3.941,00 2.599,00
Long Term Liabilities 2.542,00 3.365,00 2.911,00
Total Liabilities 7.119,00 6.927,00 6.211,00
Equity 31-12-2018 31-12-2017 31-12-2016 31-12-2015 31-12-2014
Retained Earnings 10.943,00 10.861,00 10.483,00 10.396,00 10.209,00 10.246,00
Treasury Stock
Total Stockholder Equity 11.425,00 11.254,00 11.732,00 11.580,00 11.269,00 11.054,00
Net Tangible Assets 9.295,00 8.822,00 8.995,00 8.904,00 8.315,00 8.190,00